Actively Recruiting
Cardiovascular Risk in Digital Osteoarthritis
Led by University Hospital, Clermont-Ferrand · Updated on 2024-04-03
100
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this cross-sectional case control study is to investigate the cardiovascular risk in digital osteoarthritis. This study aims to compare the cardiovascular risk between group of patients with digital osteoarthritis and control group of patients with non-osteoarthritis disease paired by measurement of carotid intima-media thickness. All participants will undergo an ultrasound scan to measure carotid intima media thickness, a clinical assessment with the rheumatologist and a cardiovascular risk assessment.
CONDITIONS
Official Title
Cardiovascular Risk in Digital Osteoarthritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult male or female subject
- Able to give informed consent to participate in research
- Affiliated with a Social Security plan
- For the digital osteoarthritis group: Diagnosed with digital osteoarthritis meeting ACR criteria with radiographic signs validated by a radiologist
- For the control group: Patients with spinal disc pathology (lumbago, radiculalgia due to disco-radicular conflict) or non-severe osteoporosis with densitometric T score between -2.5 and -3 DS
- Both groups must be seen by a rheumatology consultant at Clermont-Ferrand University Hospital
You will not qualify if you...
- Refusal to participate
- Pregnant women or nursing mothers
- Subjects under guardianship, curatorship, deprived of liberty, or court protection
- For the digital osteoarthritis group: Presence of other inflammatory rheumatism (rheumatoid arthritis, spondylarthritis, psoriatic arthritis, lupus, gout, chondrocalcinosis) or other symptomatic arthrosis affecting daily activities
- For the control group: Presence of chronic inflammatory rheumatism, digital osteoarthritis, other painful arthritic sites (knee, hip, spine), or finger pain regardless of cause
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chu Clermont Ferrand
Clermont-Ferrand, France
Actively Recruiting
Research Team
L
Lise Laclautre
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here